Urokinase receptor

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (14:35, 11 April 2024) (edit) (undo)
 
(6 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='2i9b' size='340' side='right' caption='Human uPAR (grey) complex with glycosylated uPA (magenta) and sulfate (PDB code [[2i9b]])' scene=''>
+
<StructureSection load='2i9b' size='340' side='right' caption='Human uPAR (grey) complex with glycosylated uPA (magenta) and sulfate (PDB code [[2i9b]])' scene='10/1041521/Cv/1'>
== Function ==
== Function ==
-
'''Urokinase receptor''' or '''Urokinase plasminogen activator surface receptor''' or '''CD87''' (uPAR) plays an important role in migration of T cells<ref>PMID:8283034</ref>. uPAR is a GPI-anchored membrane protein. It triggers cell signalling and regulates gene expression within the cell
+
'''Urokinase receptor''' or '''Urokinase plasminogen activator surface receptor''' or '''CD87''' (uPAR) plays an important role in migration of T cells<ref>PMID:8283034</ref>. uPAR is a GPI-anchored membrane protein. It triggers cell signalling and regulates gene expression within the cell. The invasive potential of uPAR expressing tumor cells is modulated by interaction with
-
 
+
urokinase plasminogen activator (uPA)<ref>PMID:1659573</ref>.
== Disease ==
== Disease ==
Line 11: Line 11:
== Relevance ==
== Relevance ==
-
Elevated levels of soluble uPAR are associated with kidney disease<ref>PMID:26539835</ref>. uPAR which is expressed at high levels in malignant tutors is unattractive target for treatment of cancer<ref>PMID:35303878</ref>. uPAR activity in cancer cells may counteract the activity of anticancer drugs<ref>PMID:26283964</ref>.
+
Elevated levels of soluble uPAR are associated with kidney disease<ref>PMID:26539835</ref>. uPAR which is expressed at high levels in malignant tumors is an attractive target for treatment of cancer<ref>PMID:35303878</ref>. uPAR activity in cancer cells may counteract the activity of anticancer drugs<ref>PMID:26283964</ref>.
 +
 
 +
==Structural highlights==
-
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
+
The binding of uPAR and urokinase-type plasminogen activator (uPA) is mediated by hydrophobic numerous interactions. <scene name='10/1041521/Cv/2'>In particular the interactions between uPA residue Trp30 and uPAR numerous hydrophobic residues</scene><ref>PMID:16979660</ref>.
==3D structures of urokinase receptor==
==3D structures of urokinase receptor==

Current revision

Human uPAR (grey) complex with glycosylated uPA (magenta) and sulfate (PDB code 2i9b)

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Urokinase_receptor"
Personal tools